15 September 2008
Investigations into a series of hepatitis B outbreaks linked to blood-glucose testing in residential care homes have indicated that in each case there was a serious breakdown in infection control procedures.
As a result of these incidents, the HPA is drawing up new guidance for blood-glucose testing in residential care homes.
Dr. Erika Duffell, a Consultant with the Health Protection Agency's Greater Manchester Health Protection Unit (HPU), told delegates at the Agency's annual conference at Warwick University that five incidents of onward transmission of hepatitis B occurred in residential care homes across the country, between 2004 and 2007.
"In the largest incident, hepatitis B infection was transmitted to seven people. These were predominantly elderly people, average age 75, with diabetes. Infections in these settings are particularly serious as acute hepatitis B has a high mortality rate in older people," Dr. Duffell said.
"It is suspected that transmission in these incidents resulted from staff incorrectly using individual patient finger-stick lancet devices for blood-glucose testing. Cross contamination is likely to have occurred during this process as these devices are not suitable for multiple patient use in such settings."
The Agency's advice is that for blood glucose monitoring in community care homes, staff should use either disposable single use lancing devices which are discarded after use, or a non-disposable lancing device that has been specifically designed for use on multiple patients.
Ends
Notes to editors
Last reviewed: 15 September 2008